PhaseBio Pharmaceuticals, Inc. (PHAS)

Depreciation & Amortization

$1.94M

TTM · Period ending: · USD

PHAS logo

PHAS Depreciation & Amortization

Latest reported$1.94M
PHAS Depreciation & Amortization ($92.00K → $1.94M)
High-resolution chart · PNG

PHAS depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Depreciation & Amortization — Annual fiscal periods (USD)
Period endingDepreciation & Amortization (USD)
1,793,000
508,000
174,000
105,000
96,000
92,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.